Medicine
fromwww.theguardian.com
3 weeks agoWeight loss drugs can halve heart patients' risk of early death, study finds
GLP-1 agonist weight-loss drugs substantially reduce hospitalization and premature death risk in obese heart failure patients with type 2 diabetes, up to 58%.